Logo

Acute Renal Failure

Prevention,

Treatment and Diagnostic Tests.

About Us

Everything you'll want to know about our blog. Learn what we are all about!

Learn More

Kidney Reviews

Whether you are looking to be a reviewer or read our reviews, click the button to find out more.

Reviews

Contact Us

Have a question? We love interacting with our readers.

More Details

Acute Renal Failure Group Topic List

ACUTE RENAL FAILURE 

  • Prevention
    • Antihypertensive agents
      • Antihypertensive agents for preventing acute renal failure
    • Diuretics for acute renal failure
    • Haemolytic uraemic syndrome
      • [P] Interventions for preventing haemolytic uraemic syndrome/thrombotic thrombocytopenic purpura
    • Interventions for preventing contrast-induced nephropathy (Registered title WL062)
    • Plasma volume expanders
      • Plasma volume expanders for preventing acute renal failure
    • Surgical patients
      • Interventions for preventing acute renal failure in surgical patients
        • Antihypertensive agents for protecting renal function in surgical patients
  • Treatment
    • Dialysis
      • Haemodialysis for acute renal failure
        • Frequency
        • Membranes
        • Haemodialysis solutions
      • Dialysis solutions for acute renal failure
      • Peritoneal dialysis for acute renal failure
      • Intermittent versus continuous renal replacement therapy for acute renal failure
      • Continuous veno-venous haemofiltration (CVVH) for acute renal failure
      • Continuous veno-venous haemofiltration (CVVH) for treating paraquat poisoning
    • Atrial natriuretic peptide for acute renal failure
    • Nutritional support for acute renal failure
    • Haemolytic uraemic syndrome
      • [P] Interventions for established haemolytic uraemic syndrome/ thrombotic thrombocytopenic purpura
    • Hyperkalaemia
      • [P] Emergency interventions for hyperkalaemia
    • Sodium bicarbonate supplements for acute renal failure
 

DIAGNOSTIC TESTS

  • Acute pyelonephritis
  • Cytomegalovirus (CMV) diagnostic tests
  • Iron measurements
  • Renal scarring
  • Suprapubic urine aspiration
  • Ureteric colic
 

DRUGS AND THE KIDNEY

  • Amphotericin B deoxycholate
  • Nonsteroidal anti-inflammatory drugs
    • [R] Effects of nonsteroidal anti-inflammatory drugs on post-operative renal function in normal adults
 

CHRONIC KIDNEY DISEASE

  • Acidosis control
    • [P] Correction of chronic metabolic acidosis in pre end-stage chronic renal failure
  • Anaemia control
    • Androgens regarding the chronic kidney disease anaemia
    • Darbepoetin for the anaemia of chronic kidney disease
    • Erythropoietin
      • [R] Recombinant human erythropoietin for chronic renal failure anaemia in pre-dialysis patients
    • Haemoglobin and haematocrit targets
      • [R] Haemoglobin and haematocrit targets for the anaemia of chronic kidney disease
  • Antihypertensive agents
    • [P] Antihypertensive treatment for non-diabetic kidney disease
  • Cardiovascular protection
    • Interventions for preventing cardiovascular death in chronic kidney disease
  • Cholesterol management
    • Interventions for lowering cholesterol in pre-dialysis patients
  • Exercise
    • [P] Exercise training for uraemic patients
  • Growth hormone
    • [R] Growth hormone for children with chronic renal failure
  • Hyperhomocysteinaemia
    • Interventions for hyperhomcysteinaemia in pre-dialysis patients
  • Infection
    • Interventions for preventing chickenpox (varicella) in children with chronic kidney disease
  • Interventions for preventing the progression of chronic kidney disease
    • Antihypertensive agents
    • Dietary interventions
      • L-arginine
      • Oral absorbents
      • Protein restriction
        • [R] Low protein diets for chronic renal failure in non diabetic adults
    • Ibopamine for preventing the progression of chronic kidney disease
  • Nutritional supplements
    • Levocarnitine for chronic kidney disease (registered title GS025)
    • Interventions for malnutrition in chronic kidney disease (Registered title GS084)
  • Renal bone disease
    • Interventions for preventing renal bone disease in chronic kidney disease (Title registered GS085)
 

END-STAGE KIDNEY DISEASE

  • GENERAL MANAGEMENT
    • Anabolic steroids
    • Anaemia control
      • Darbepoetin
      • Erythropioetin
        • [R] Frequency of administration of recombinant human erythropoietin for anaemia of end stage renal disease in dialysis patients
      • Iron supplements
    • Blood pressure control
      • Hypertension
      • Hypotension
    • Cardiovascular
      • [P] Interventions for lowering plasma homocysteine levels in dialysis patients
    • Cholesterol management
      • Dietary interventions for lowering cholesterol in dialysis patients
      • Medical Interventions
        • [P] HGM CoA reductase inhibitors (statins) for lowering cholesterol in dialysis patients
    • Depression
      • [P] Psychological interventions for depression in dialysis patients
      • [P] Physical measures for treating depression in dialysis patients
    • Hyperalbuminaemia
    • Hyperkalaemia
    • Itching
    • Nutritional supplements
    • Renal function
      • Interventions for improving renal function in end-stage kidney disease
    • Sexual dysfunction
      • Erectile dysfunction
    • Treatment options
      • [R] Continuous ambulatory peritoneal dialysis (CAPD) versus hospital or home haemodialysis for end stage renal disease in adults
      • [P] Dialysis and transplantation for end stage renal disease in adults
  • HAEMODIALYSIS
    • Access
      • Catheters
      • Contrast agents for haemodialysis access
      • Needling devices
      • Vascular access
    • Dialysate
      • Solutions
      • Dialysate purity
    • Dialysers
      • Membranes
        • [R] Cellulose, modified cellulose and synthetic membranes in the haemodialysis of patients with end stage renal disease.
      • Flux
        • High versus low flux haemodialysis membranes for end stage renal disease (Registered title KSR004)
      • Dialyser reuse
      • Dual dialysers
      • Ultrafiltration control
    • Dose/Duration
      • Automated versus standard ultrafiltration for haemodialysis
      • Haemodialysis frequency for end-stage kidney disease (registered title GP065)
      • Kt/v and creatinine clearance targets
      • Short versus standard duration haemodialysis
    • Infection
      • Exit site and tunnel infections
      • Bacteraemia
    • Other
      • Erythropoietin
      • Fluid control
      • Interventions for hyperhomocysteinaemia in haemodialysis patients (Registered title KP082)
      • Interventions for preventing and treating cramps during haemodialysis
      • Interventions for preventing dialysis-related hypotension
      • Interventions for treating restless leg syndrome in haemodialysis patients (Registered title KW017)
      • Interventions for treating elevated ferritin levels in haemodialysis patients
      • Iron for long-term haemodialysis patients
      • Vitamin C infusions
    • Thrombosis/Patency
      • Anticoagulation
      • Interventions for preventing haemodialysis access blockage
      • Interventions for preventing clotting of extracorporeal circuits
      • Interventions for preventing thrombosis in haemodialysis grafts
      • Priming solutions for haemodialysis
      • Prophylactic angioplasty for extending patency in haemodialysis grafts
      • Surgical versus endovascular management of thrombosed dialysis access grafts
    • Treatment options
      • Conventional versus nocturnal haemodialysis for end-stage kidney disease
      • Home versus in-centre haemodialysis (registered title GP065)
  • PERITONEAL DIALYSIS
    • Access
      • The Catheter insertion techniques
      • Catheter placement
      • Tenckhoff catheter configuration
      • Transfer systems
        • [R] Double bag or Y-set versus standard transfer systems for continuous ambulatory peritoneal dialysis in end stage renal disease
    • Anticoagulation
      • Wafarin for continuous ambulatory peritoneal dialysis
    • Dialysate
      • Dialysis solutions
      • Exchange volumes
    • Dose/Duration
      • Clearance targets
    • Infection
      • [P]Anti-infective (antiseptics and antibiotics) agents for preventing peritonitis in peritoneal dialysis patients peritonitis
      • [P]Catheter type, placement and insertion techniques for preventing peritonitis in peritoneal dialysis patients
    • Other
      • Interventions for improving nutritional status
      • Interventions for preserving residual kidney function
      • Interventions for preventing acidosis
    • Treatment options
 

GENERAL NEPHROLOGY

  • GLOMERULAR DISEASES
    • Diabetic kidney disease
      • Diabetic education programmes for dialysis patients
      • Glycosaminoglycan for preventing and treating diabetic kidney disease
      • Salt diets for preventing and treating diabetic kidney disease
      • Antihypertensive agents
        • [P] Antihypertensive agents for preventing diabetic kidney disease
        • [P] Antihypertensive agents for preventing the progression of diabetic kidney disease
    • Focal glomerulosclerosis
      • Antihypertensive agents
      • Immunosuppressive agents
        • [P] Immunosuppressive treatment for focal segmental glomerulosclerosis in adults with nephrotic syndrome
    • Henoch-Schonlein purpura
      • Interventions for preventing renal complications in Henoch-Schonlein purpura
    • IgA nephropathy
      • [P] Immunosuppressive and cytotoxic agents for treating IgA nephropathy
      • [P] Non-immunosuppressive treatment for IgA nephropathy
    • Lupus nephritis
      • Treatment
        • [P] Treatment for lupus nephritis
    • Membranoproliferative glomerulonephritis
      • [P] Therapeutic interventions for idiopathic membranoproliferative glomerulonephritis
    • Membranous nephopathy
      • [P] Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome
    • Minimal-change nephroapathy
      • Treatment
        • Corticosteroids for minimal change nephropathy in adults with nephrotic syndrome (registered title NBM010)
        • Non-corticosteroid treatment
    • Nephrotic Syndrome
      • Diuretics
      • Infection
        • [P] Interventions for preventing infection in nephrotic syndrome
      • Interventions for preventing thrombosis
      • Lipid-lowering agents
      • Treatment
        • [R] Corticosteroid therapy for nephrotic syndrome in children
        • [R] Non-corticosteroid treatment for nephrotic syndrome in children
        • [P] Interventions for idiopathic steroid-resistant nephrotic syndrome in children
    • Rapidly progressive glomerulonephritis
      • Treatment
        • [P] Treatment for renal vasculitis and Goodpasture's disease in adults
  • POLYCYSTIC KIDNEY DISEASE
    • Blood pressure control
    • Cholesterol management
  • KIDNEY BIOPSIES
 

PROCESS OF CARE 

  • TRANSPLANTATION
    • Medication compliance
  • URINARY TRACT INFECTION
    • Telephone versus in-office management
  • END-STAGE KIDNEY DISEASE
      Blood pressure control in haemodialysis patients
 

TRANSPLANTATION 

  • KIDNEY
    • Antihypertensive agents
      • Antihypertensive agents
        • [P] Antihypertensive agents for recipients of kidney transplant
      • Calcium antagonists
        • [R] Calcium channel blockers for preventing acute tubular necrosis in renal transplant recipients
      • Diuretics
    • Antiplatelet activating factor
    • Atrial natriuretic peptide
    • Cholesterol management
    • Dopamine for preventing early graft dysfunction in kidney transplantation (Registered title ASE078)
    • Erythrocytosis
    • General care
    • Immunosuppression
      • Antibody immunosuppression
        • Monoclonal - Interleukin 2 receptor antagonists
          • [P] Interleukin 2 receptor antagonists for recipients of kidney transplant
        • Polyclonal
      • Azathioprine
      • Corticosteroids
        • Steroid withdrawal
        • Steroid tapering
        • Low versus high dose steroids
      • Cyclosporin
      • Double versus triple therapy
      • FTY720
      • Mizoribine
      • Mycophenolate mofetil
        • Mycophenolate mofetil versus azathiprine for recipients of kidney transplant (registered title AWE069)
      • Sirolimus
        • [P] Sirolimus and everolimus for recipients of kidney transplant
      • Tacrolimus
        • [P] Tacrolimus for recipients of kidney transplant
    • Infection
      • Interventions for preventing pneumocystis pneumonia in recipients of kidney transplant
    • Hyperhomocysteinaemia
    • Nutritional supplements
      • Fish oil
      • L-arginine
      • immunonutrients
      • Vitamin C
    • Pentoxifylline
    • Renal bone disease
      • Phosphate replacement therapy
    • Urological complications
        Intra-operative ureteric stenting for preventing urological complications in recipients of kidney transplant (Registered title CHW027)
  • KIDNEY AND OTHER SOLID ORGANS
    • Antibiotics
    • KIDNEY-PANCREAS
      • Immunosuppression
        • Antibody immunosuppression
          • [P] Antibody immunosuppression pancreas and kidney-pancreas transplant recipients
        • Corticosteroids
        • Tacrolimus
      • Donor-organ preservation
    • INFECTION
      • Cytomegalovirus (CMV)
        • [P] Interventions for preventing cytomegalovirus disease in solid organ transplant recipients
        • [R] Cytomegalovirus prophylaxis with antiviral agents for solid organ transplantation
      • Fungal infections
        • [P] Antifungal agents for preventing fungal infections in solid organ transplant recipients
  • SURGERY TECHNIQUES
    • Antibiotics
    • Anticoagulants
    • Blood transfusions
      • Donor-specific
      • Recipient
    • Donor organ preservation techniques
    • Surgical techniques
      • Single versus simultaneous-double kidney transplantation
 

URINARY TRACT INFECTION 

  • Prevention
    • Lower urinary tract infection
      • [R] Cranberries for preventing urinary tract infections
      • [R] Long-term antibiotics for preventing recurrent urinary tract infection in children
      • [R] Methenamine hippurate for preventing urinary tract infections
      • [P] Interventions for preventing recurrent urinary tract infection in women
    • Pyelonephritis
    • Urinary tract infection - recipients of kidney transplant
    • Urologic investigations
  • Treatment
    • Asymptomatic urinary tract infection
      • [P] Antibiotics for asymptomatic urinary tract infection in the elderly
    • Lower urinary tract infection
      • [R] Antibiotic duration for treating uncomplicated, symptomatic lower urinary tract infections in elderly women
      • [R] Cranberries for treating urinary tract infections
      • [P] Duration of antibacterial treatment for uncomplicated urinary tract infection in women
      • [P] Modes of administration of antibiotics for symptomatic urinary tract infections
      • [P] Quinolones for uncomplicated acute cystitis in women
      • [R] Short versus standard duration oral antibiotic therapy for acute urinary tract infection in children
    • Pyelonephritis
      • [R] Antibiotics for acute pyelonephritis in children
  • Urine collection
    • Interventions for collecting urine samples
 

UROLOGY

  • RENAL COLIC
    • Prevention
    • Treatment
      • Acupuncture
      • Agonist-antagonists
      • Glucagon
      • Nitrates
      • Non-opiate analgesia
      • Nonsteroidal anti-inflammatory drugs
        • [P] Nonsteroidal anti-inflammatory drugs (NSAIDs) versus opioids for acute renal colic
      • Prostaglandin inhibitors
  • KIDNEY STONES
    • Idipathic hypercalciuria
      • Dietary interventions for preventing complications in idiopathic hypercalciuria (Registered title JES081)
      • Pharmacological intervantions for preventing complications in idiopathic hypercalciuria (Registered title JES080)
    • Prevention
      • Water intake
        • [P] Water for preventing urinary calculi
    • Treatment
      • Extra-corporeal shock wave lithotripsy
        • Diuresis
        • Peri-operative stenting
        • Pain relief
      • Interventions for hypercalciuria
      • Intravenous fluids for treating acute nephrolithiasis (Registered title AWO003)
  • VESICOURETERAL REFLUX
    • Treatment
      • [P] Interventions for primary vesicoureteric reflux
ambulance ambulance-white

Stay Knowledgeable

Keep informed about renal disease, and stay out of the emergency room.

heart-ic heart-ic-white

Healthy Lifestyle

Experience life to the fullest with healthy kidneys.

phone phone-white

Urgent Care

If you feel any of the symptoms we mention on this site, find an urgent care medical center near you quickly.

appoinment-latter appoinment-latter-white

Kidney Checklist

Use information above to keep safe from Proteinuria or Diabetes.

appoinmentSend us your questions!

Send Email Notification